Med vs COSA
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
Med
This app assists healthcare professionals in managing heart failure medications. It provides evidence-based algorithms and recommendations for initiating, titrating, and monitoring six common drug classes based on Canadian guidelines.
- Medication initiation and titration guidance
- Dosing information
- Evidence-based algorithms
- Clinical pearls
- Drug class specific recommendations
- References
Read full descriptionHide full description
The Med-HF App supports healthcare professionals in the initiation, titration, assessment and monitoring of 6 drug classes commonly used to treat heart failure: ACEIs/ARBs, Beta-Blockers, MRA: Mineralocorticoid Receptor Antagonist, ARNI: Angiotensin Receptor Blocker / Neprilysin Inhibitor, Ivabradine, Diuretics. This App interactively walks healthcare professionals through evidence-based algorithms, specific to these 6 drug classes, and recommends appropriate actions and considerations based on 2018 Canadian Cardiovascular Society Heart Failure Guidelines. Features: • Recommendations for medication initiation, titration, assessment and monitoring • Dosing information • References • Clinical pearls • General approach and drug class algorithms
COSA
Access essential drug information and advanced patient resources. This app provides a portion of licensed drug data from a leading healthcare information provider, based on industry-standard databases.
- Essential drug information
- Advanced patient resources
- Licensed drug data
- Industry-standard databases
- Physician-focused resources
Read full descriptionHide full description
Find essential drug information & advanced patient resources. Physicians Office Resource licenses drug information data from First DataBank and provides a portion of it as a free service to its physician-users. First DataBank is the leading provider of electronic drug information to the healthcare industry. Based on the widely accepted industry standard — the National Drug Data File® — NDDF Plus databases are backed by the most clinically verifiable evidence gathered to date.
Screenshots
Verdict
The clearest difference is ads: Med at none against COSA's shown. Med also leads on monetization model (free vs ad-supported). COSA's advantage is update cadence (every 3 months vs every 35 months). On price, in-app purchases, device support and iOS requirement there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
Med ships an update every 35 months, COSA every 3 months. The most recent releases landed on November 1, 2026 and November 3, 2026 respectively.
| Parameter | Med | COSA |
|---|---|---|
| Price | Free | Free |
| Rating | — | 3.7 (3 ratings) — better |
| Positive reviews | 100.0% of reviews | — |
| Number of ratings | — | 3 — better |
| Update frequency | Every 35 months | Every 3 months — better |
| Ads | No — better | Yes |
| In-app purchases | No | No |
| Monetization | Free — better | Ad-supported |
| Devices | iPhone, iPod | iPhone, iPod |
| Requires iOS | 11.0 | 11.0 |
| Further details — not scored | ||
| Size | 15 MB | 28 MB |
| Age rating | 12+ | 4+ |
| Developer | AHS | MEDICAL EDUCATION RESOURCES, LLC |
Customer experience
Med
COSA
In-app purchases
Med
No in-app purchases
COSA
No in-app purchases









